Philips

PHG

Market cap $24.8B

May 18, 2026 From imaging to AI-enabled guidance, Philips connects technologies into a unified workflow to improve efficiency, reduce radiation exposure and support procedural confidence Amsterdam, the Netherlands – As cardiac procedures become more complex, interventional cardiologists must balance the need for precise imaging and decision-making with growing pressure to reduce radiation exposure for both patients and staff. At EuroPCR 2026 in Paris (May 19–22), Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase how advances in imaging, physiology and real-time guidance can help clinicians manage complexity while supporting safer, lower-dose procedures.

May 18, 2026      Greater differentiation of clinical details through contrast-rich images with reduced background noise​ For coronary procedures, a new ultra-low dose protocol employs over 50% less X-ray radiation dose [1] First SmartIQ clinical pilot study published in JSCAI, further building on Philips' strong track record in evidence generation [2] Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced Philips SmartIQ, a breakthrough coronary imaging technology for its Azurion image-guided therapy. Developed in collaboration with leading cardiovascular centers, SmartIQ is designed to address one of the field's most fundamental challenges: the trade-off between image quality and radiation exposure for patients and clinical staff.

May 18, 2026 Philips-led consortium selected through Karolinska University Hospital-led Region Stockholm tender to deliver advanced remote monitoring for complex patients Stockholm, Sweden - Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that a consortium composed of Philips, Cuviva and Vingmed has been selected to support Region Stockholm's hospital-at-home initiative, enabling hospital-level care to be delivered in patients' homes across the region. The consortium was selected through a tender led by Karolinska University Hospital for an advanced remote-monitoring program serving patients with complex or chronic conditions.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

May 8, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2026, including: Appointment of John DeFord (American, 1962) as new member of the Supervisory Board, with effect from May 8, 2026. Re-appointment of Paul Stoffels (Belgian, 1962), Herna Verhagen (Dutch, 1966) and Sanjay Poonen (American, 1969) as members of the Supervisory Board, with effect from May 8, 2026.

PHG stock gains after Philips posts Q1 earnings, with 4% comparable sales growth and improved cash flow despite lower revenues.

CEO of Philips, Roy Jakobs reviews strong earnings highlighting margin expansion despite inflation and a solid start to the year. He notes the company reiterated full-year guidance and remains focused on controlling what it can within earnings execution.

Koninklijke Philips N.V. (NYSE:PHG) shares were trading higher on Wednesday as the company reported strong order intake and comparable sales growth in its recent first quarter 2026 performance.

Koninklijke Philips N.V. (PHG) Q1 2026 Earnings Call Transcript

Philips and Pandora on Wednesday said they have applied for tariff reimbursement. Several other firms mentioned tariffs as negatively impacting results in a slew of earnings updates.